Dennis Göerlich

871 total citations · 1 hit paper
11 papers, 427 citations indexed

About

Dennis Göerlich is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Cancer Research. According to data from OpenAlex, Dennis Göerlich has authored 11 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Hematology and 3 papers in Cancer Research. Recurrent topics in Dennis Göerlich's work include Acute Myeloid Leukemia Research (3 papers), Breast Cancer Treatment Studies (2 papers) and Polyomavirus and related diseases (1 paper). Dennis Göerlich is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Breast Cancer Treatment Studies (2 papers) and Polyomavirus and related diseases (1 paper). Dennis Göerlich collaborates with scholars based in Germany, United Kingdom and New Zealand. Dennis Göerlich's co-authors include Andreas Faldum, Holger Reinecke, Joachim Gerß, Nasser Malyar, Ursula Marschall, Eva Freisinger, Jeanette Koeppe, Jan Braess, Karsten Spiekermann and Wolfgang Hiddemann and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and European Heart Journal.

In The Last Decade

Dennis Göerlich

11 papers receiving 425 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

2022 101 citations Holger Reinecke, Christiane Engelbertz et al. Circulation profile →

Peers

Countries citing papers authored by Dennis Göerlich

Since Specialization

Citations

This map shows the geographic impact of Dennis Göerlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Göerlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Göerlich more than expected).

Fields of papers citing papers by Dennis Göerlich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Göerlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Göerlich. The network helps show where Dennis Göerlich may publish in the future.

Co-authorship network of co-authors of Dennis Göerlich

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Göerlich. A scholar is included among the top collaborators of Dennis Göerlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Göerlich. Dennis Göerlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Defining the Role of Radiotherapy for Indolent, Primary Cutaneous B-Cell Lymphoma – First Results from a Multicenter Registry by the International Lymphoma Radiation Oncology Group (ILROG) 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Markus F. Oertel, Dennis Göerlich, (unknown), S. Morris, (unknown), Mark J. Levis, (unknown), (unknown), Monica Chelius, (unknown), Daphne Roos, Youlia Kirova, Rainer Fietkau, (unknown), (unknown), (unknown), Stephanie A. Terezakis, Reiner Hoppe, (unknown)	1
2	A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study breakdown → 2022 ·Circulation ·Holger Reinecke, Christiane Engelbertz, Rupert Bauersachs, Günter Breithardt, (unknown), Joachim Gerß, Karl Georg Hæusler, Bernd Hewing, Joachim Hoyer, (unknown), Thomas Klingenheben, Guido Knapp, Lars Christian Rump, (unknown), Christoph Wanner, Paulus Kirchhof, Dennis Göerlich	101
3	Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis 2019 ·European Heart Journal ·Eva Freisinger, Jeanette Koeppe, Joachim Gerß, Dennis Göerlich, Nasser Malyar, Ursula Marschall, Andreas Faldum, Holger Reinecke	124
4	Blood clot removal by cryoextraction in critically ill patients with pulmonary hemorrhage 2019 ·Journal of Thoracic Disease ·L. H. Schmidt, Arik Bernard Schulze, Dennis Göerlich, Christoph Schliemann, Torsten Keßler, (unknown), (unknown), Felix Rosenow, Jan Sackarnd, Georg Evers, Michael Möhr	11
5	Noncaseating granulomatous diseases in germ cell cancer patients–A single-center experience 2019 ·Urologic Oncology Seminars and Original Investigations ·L. H. Schmidt, Sebastian Huss, (unknown), Arik Bernard Schulze, Georg Evers, Christoph Schliemann, (unknown), (unknown), (unknown), Peter Barth, Karsten Wiebe, Dennis Göerlich, Wolfgang E. Berdel, (unknown), Michael Möhr	2
6	Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia 2018 ·Leukemia ·Maja Rothenberg‐Thurley, Susanne Amler, Dennis Göerlich, Thomas Köhnke, Nikola P. Konstandin, Stephanie Schneider, Maria C. Sauerland, Tobias Herold, Max Hubmann, Bianka Ksienzyk, Evelyn Zellmeier, Stefan K. Bohlander, Marion Subklewe, Andreas Faldum, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann, Klaus H. Metzeler	106
7	Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older 2018 ·Haematologica ·(unknown), Maja Rothenberg‐Thurley, Maria C. Sauerland, Tobias Herold, Hanna Janke, Bianka Ksienzyk, Nikola P. Konstandin, Dennis Göerlich, Utz Krug, Andreas Faldum, Wolfgang E. Berdel, Bernhard Wörmann, Jan Braess, Stephanie Schneider, Marion Subklewe, Stefan K. Bohlander, Wolfgang Hiddemann, Karsten Spiekermann, Klaus H. Metzeler	76
8	Persistence of Driver Mutations during Complete Remission Associates with Shorter Survival and Contributes to the Inferior Outcomes of Elderly Patients with Acute Myeloid Leukemia 2016 ·Haematologica ·Maja Rothenberg‐Thurley, Susanne Amler, Dennis Göerlich, M. C. Sauerland, S. Schneider, Nikola P. Konstandin, Sebastian Schaaf, Aarif M.N. Batcha, Kathrin Bräundl, Bianka Ksienzyk, Evelyn Zellmeier, Ulrich Mansmann, Michael Fiegl, Marion Subklewe, Stefan K. Bohlander, Andreas Faldum, Wolfgang Hiddemann, Karsten Spiekermann, Jan Braess, Klaus H. Metzeler	2
9	Development of a novel nomogram predicting nonsentinel lymph node metastases among patients with breast cancer after neoadjuvant chemotherapy (NACT): A transSENTINA substudy. 2014 ·Journal of Clinical Oncology ·Cornelia Liedtke, Dennis Göerlich, Ingo Bauerfeind, Tanja Fehm, Barbara Fleige, Annette Lebeau, Annette Staebler, Gϋnter von Minckwitz, Michael Untch, Thorsten Kuehn	1
10	Multitasking and Wages 2013 ·SSRN Electronic Journal ·Dennis Göerlich, Dennis J. Snower	2
11	Predicting nonsentinel lymph node metastases using established nomograms among patients with breast cancer after primary systemic therapy (PST): The transSENTINA substudy. 2013 ·Journal of Clinical Oncology ·Cornelia Liedtke, Dennis Göerlich, Kimberly J. Van Zee, (unknown), Ingo Bauerfeind, Tanja Fehm, Barbara Fleige, G Helms, Annette Lebeau, (unknown), Annette Staebler, Gϋnter von Minckwitz, Michael Untch, Thorsten Kühn	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact